Comment on “Metformin Decreases Thyroid Volume and Nodule Size in Subjects with Insulin Resistance: A Preliminary Study”
[...]it is understood that choosing an upper limit of TSH 4.0 mU/L may not be appropriate for older adults. [...]using only body mass index (BMI) in such a heterogeneous group could lead to false results.
Gespeichert in:
| Veröffentlicht in: | Medical principles and practice 2017-03, Vol.26 (2), p.199-200 |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 200 |
|---|---|
| container_issue | 2 |
| container_start_page | 199 |
| container_title | Medical principles and practice |
| container_volume | 26 |
| creator | Cintosun, Umit Naharci, Mehmet Ilkin Doruk, Huseyin |
| description | [...]it is understood that choosing an upper limit of TSH 4.0 mU/L may not be appropriate for older adults. [...]using only body mass index (BMI) in such a heterogeneous group could lead to false results. |
| doi_str_mv | 10.1159/000452955 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_journals_1990821988</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1835530187</sourcerecordid><originalsourceid>FETCH-LOGICAL-c482t-6f9fd1eb1ee5b5113a9f215c22cdb92712b0498404644245e02c544a53e7e453</originalsourceid><addsrcrecordid>eNpt0c1u1DAQB3ALgWhZOHBHyFIvcAh4_NEkHJCq5atSCyt2xdVynEnXSxIvdgJaxKEPAi_XJ8FoSwSIky3Pz3_NaAi5D-wJgCqfMsak4qVSN8ghSC4yBgpupjsDyHKVwwG5E-MmsUIIdpsc8LxgXEp1SL7NfddhP1Df06vL7-c4ND50rqcv0AY0ESNdrXfBu5p-8O3YITV9Td_6emyRLt1XpMkux2qDdoj0ixvW9LSPY5te32N0cTC9xWf0hC4Cti4Fm7Cjy2Gsd1eXP-6SW41pI967Pmdk9erlav4mO3v3-nR-cpZZWfAhO27KpgasAFFVCkCYsuGgLOe2rkqeA6-YLAvJ5LGUXCpk3CopjRKYo1RiRp7vY7dj1WFt07jBtHobXJe60d44_Xeld2t94T9rpYpCKJECHl0HBP9pxDjozkWLbWt69GPUkJQSDIo80aN_6MaPoU_TaShLVnAoU-aMPN4rG3yMAZupGWD610r1tNJkH_7Z_SR_7zCBB3vw0YQLDBOY_h_9t3y-WOyF3taN-AlKvLL8</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1990821988</pqid></control><display><type>article</type><title>Comment on “Metformin Decreases Thyroid Volume and Nodule Size in Subjects with Insulin Resistance: A Preliminary Study”</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>Karger Open Access</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>Cintosun, Umit ; Naharci, Mehmet Ilkin ; Doruk, Huseyin</creator><creatorcontrib>Cintosun, Umit ; Naharci, Mehmet Ilkin ; Doruk, Huseyin</creatorcontrib><description>[...]it is understood that choosing an upper limit of TSH 4.0 mU/L may not be appropriate for older adults. [...]using only body mass index (BMI) in such a heterogeneous group could lead to false results.</description><identifier>ISSN: 1011-7571</identifier><identifier>EISSN: 1423-0151</identifier><identifier>DOI: 10.1159/000452955</identifier><identifier>PMID: 27802445</identifier><language>eng</language><publisher>Basel, Switzerland: S. Karger AG</publisher><subject>Humans ; Hypoglycemic Agents ; Insulin ; Insulin Resistance ; Letter to the Editor / Reply ; Metformin ; Older people ; Thyroid Gland ; Thyroid Nodule ; Thyrotropin</subject><ispartof>Medical principles and practice, 2017-03, Vol.26 (2), p.199-200</ispartof><rights>2016 S. Karger AG, Basel</rights><rights>Copyright © 2016 by S. Karger AG, Basel 2016</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5588353/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5588353/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,864,885,27634,27923,27924,53790,53792</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27802445$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Cintosun, Umit</creatorcontrib><creatorcontrib>Naharci, Mehmet Ilkin</creatorcontrib><creatorcontrib>Doruk, Huseyin</creatorcontrib><title>Comment on “Metformin Decreases Thyroid Volume and Nodule Size in Subjects with Insulin Resistance: A Preliminary Study”</title><title>Medical principles and practice</title><addtitle>Med Princ Pract</addtitle><description>[...]it is understood that choosing an upper limit of TSH 4.0 mU/L may not be appropriate for older adults. [...]using only body mass index (BMI) in such a heterogeneous group could lead to false results.</description><subject>Humans</subject><subject>Hypoglycemic Agents</subject><subject>Insulin</subject><subject>Insulin Resistance</subject><subject>Letter to the Editor / Reply</subject><subject>Metformin</subject><subject>Older people</subject><subject>Thyroid Gland</subject><subject>Thyroid Nodule</subject><subject>Thyrotropin</subject><issn>1011-7571</issn><issn>1423-0151</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>M--</sourceid><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNpt0c1u1DAQB3ALgWhZOHBHyFIvcAh4_NEkHJCq5atSCyt2xdVynEnXSxIvdgJaxKEPAi_XJ8FoSwSIky3Pz3_NaAi5D-wJgCqfMsak4qVSN8ghSC4yBgpupjsDyHKVwwG5E-MmsUIIdpsc8LxgXEp1SL7NfddhP1Df06vL7-c4ND50rqcv0AY0ESNdrXfBu5p-8O3YITV9Td_6emyRLt1XpMkux2qDdoj0ixvW9LSPY5te32N0cTC9xWf0hC4Cti4Fm7Cjy2Gsd1eXP-6SW41pI967Pmdk9erlav4mO3v3-nR-cpZZWfAhO27KpgasAFFVCkCYsuGgLOe2rkqeA6-YLAvJ5LGUXCpk3CopjRKYo1RiRp7vY7dj1WFt07jBtHobXJe60d44_Xeld2t94T9rpYpCKJECHl0HBP9pxDjozkWLbWt69GPUkJQSDIo80aN_6MaPoU_TaShLVnAoU-aMPN4rG3yMAZupGWD610r1tNJkH_7Z_SR_7zCBB3vw0YQLDBOY_h_9t3y-WOyF3taN-AlKvLL8</recordid><startdate>20170301</startdate><enddate>20170301</enddate><creator>Cintosun, Umit</creator><creator>Naharci, Mehmet Ilkin</creator><creator>Doruk, Huseyin</creator><general>S. Karger AG</general><scope>M--</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20170301</creationdate><title>Comment on “Metformin Decreases Thyroid Volume and Nodule Size in Subjects with Insulin Resistance: A Preliminary Study”</title><author>Cintosun, Umit ; Naharci, Mehmet Ilkin ; Doruk, Huseyin</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c482t-6f9fd1eb1ee5b5113a9f215c22cdb92712b0498404644245e02c544a53e7e453</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Humans</topic><topic>Hypoglycemic Agents</topic><topic>Insulin</topic><topic>Insulin Resistance</topic><topic>Letter to the Editor / Reply</topic><topic>Metformin</topic><topic>Older people</topic><topic>Thyroid Gland</topic><topic>Thyroid Nodule</topic><topic>Thyrotropin</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Cintosun, Umit</creatorcontrib><creatorcontrib>Naharci, Mehmet Ilkin</creatorcontrib><creatorcontrib>Doruk, Huseyin</creatorcontrib><collection>Karger Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Medical principles and practice</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Cintosun, Umit</au><au>Naharci, Mehmet Ilkin</au><au>Doruk, Huseyin</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Comment on “Metformin Decreases Thyroid Volume and Nodule Size in Subjects with Insulin Resistance: A Preliminary Study”</atitle><jtitle>Medical principles and practice</jtitle><addtitle>Med Princ Pract</addtitle><date>2017-03-01</date><risdate>2017</risdate><volume>26</volume><issue>2</issue><spage>199</spage><epage>200</epage><pages>199-200</pages><issn>1011-7571</issn><eissn>1423-0151</eissn><abstract>[...]it is understood that choosing an upper limit of TSH 4.0 mU/L may not be appropriate for older adults. [...]using only body mass index (BMI) in such a heterogeneous group could lead to false results.</abstract><cop>Basel, Switzerland</cop><pub>S. Karger AG</pub><pmid>27802445</pmid><doi>10.1159/000452955</doi><tpages>2</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1011-7571 |
| ispartof | Medical principles and practice, 2017-03, Vol.26 (2), p.199-200 |
| issn | 1011-7571 1423-0151 |
| language | eng |
| recordid | cdi_proquest_journals_1990821988 |
| source | MEDLINE; DOAJ Directory of Open Access Journals; Karger Open Access; EZB-FREE-00999 freely available EZB journals; PubMed Central |
| subjects | Humans Hypoglycemic Agents Insulin Insulin Resistance Letter to the Editor / Reply Metformin Older people Thyroid Gland Thyroid Nodule Thyrotropin |
| title | Comment on “Metformin Decreases Thyroid Volume and Nodule Size in Subjects with Insulin Resistance: A Preliminary Study” |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-11T13%3A35%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Comment%20on%20%E2%80%9CMetformin%20Decreases%20Thyroid%20Volume%20and%20Nodule%20Size%20in%20Subjects%20with%20Insulin%20Resistance:%20A%20Preliminary%20Study%E2%80%9D&rft.jtitle=Medical%20principles%20and%20practice&rft.au=Cintosun,%20Umit&rft.date=2017-03-01&rft.volume=26&rft.issue=2&rft.spage=199&rft.epage=200&rft.pages=199-200&rft.issn=1011-7571&rft.eissn=1423-0151&rft_id=info:doi/10.1159/000452955&rft_dat=%3Cproquest_pubme%3E1835530187%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1990821988&rft_id=info:pmid/27802445&rfr_iscdi=true |